期刊文献+

不同剂量复方甘草酸苷注射液治疗重型肝炎的对比分析 被引量:2

不同剂量复方甘草酸苷注射液治疗重型肝炎的对比分析
下载PDF
导出
摘要 目的对比分析不同剂量复方甘草酸苷注射液治疗重型肝炎的临床疗效。方法将2009年5月~2011年5月收治的54例重型肝炎患者随机分为高剂量组和低剂量组,每组各27例,观察比较两组治疗效果。结果两组凝血酶原活动度、肝功能指标比较差异显著(P<0.05),具有统计学意义。结论不同剂量复方甘草酸苷注射液治疗重型肝炎皆能有效改善临床症状,但早期应用高剂量治疗能够显著改善肝功能。 Objective Comparative analysis of different doses of Compound Glycyrrhizin Injection in the treatment of severe hepatitis clinical efficacy. Methods From May 2011 to May 2009 in our hospital for severe hepatitis patients 54 cases, divided into high dose and low dose group,27 eases in each, were compared between the two groups therapeutic effect. Results Two groups of prothrombin activity, liver function indices were significantly different (P〈0.05), with statistical significance. Conclusion Compound Glycyrrhizin Injection at different doses in the treatment of severe hepatitis can effectively improve the clinical symptoms, but the early use of high-dose therapy can significantly improve liver function.
作者 林青 李媛
出处 《当代医学》 2012年第22期136-137,共2页 Contemporary Medicine
关键词 不同剂量 复方甘草酸苷注射液 重型肝炎 肝功能 Different dose Recurrence of glycyrrhizin injection Severe hepatitis Liver function
  • 相关文献

参考文献4

二级参考文献12

  • 1刘君澜,白永敏,田庚善.复方甘草酸苷在肝病领域的应用进展[J].中国药房,2006,17(23):1828-1830. 被引量:18
  • 2Enomoto N. Mutations in the non-structural protein 2A gene and response to interferon in patients with chronic hepatitis C virus ibinfection[J]. New Engl J Med , 1996,13(34) : 77.
  • 3Kumada H. Long-term treatment of chronic hepatitis C with glycyrrhizin [stronger neo-minophagen C (SNMC)] for preventing liver cirrhosis and hepatocellular carcinoma [J]. Oncology,2002;62 Suppl11:94.
  • 4Tarao K, Rino Y, Takemiya S, et al. Close association between high serum ALT and more rapid recurrence of hepatocellular carcinoma in hepatectomized patients with HCV associated liver cirrhosis and hepatocellular carcinoma[J]. Intervirology, 2000; 43: 20.
  • 5Toshihiro O, Kazunori K, Okio H. Hepatoprotective drugs for the treatment of virus-induced chronic hepatitis: from hypercarcinogenic state to hypocarcinogenic state[J]. Jpn J Pharmacol, 2001; 87:177.
  • 6Okamoto T. The protective effect of glycyrrhizin on antiFas antibody-induced hepatitis in mice [J]. Eur J Pharmacol,2000; 387: 229.
  • 7Okamoto T, Yoshida S, Kobayashi T,et al. Inhibition of concanavalin A-induced hepatitis by coumarin derivatives [J].Jpn J Pharmacol,2001 ;85:95.
  • 8Shiro I, Toshiro T, Takashi M, et al. Therapeutic effects of Stronger Neo-Minophagen C at different doses on chronic hepatitis and liver cirrhosis [J]. Hepatology Research, 2001; 19: 31.
  • 9中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14010
  • 10成军,张玲霞,斯崇文,庄辉.第十次全国病毒性肝炎与肝病学术会议纪要[J].中华传染病杂志,2001,19(1):53-55. 被引量:109

共引文献18

同被引文献10

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部